Literature DB >> 18072593

Expression profiling of archival renal tumors by quantitative PCR to validate prognostic markers.

Sean T Glenn1, Craig A Jones, Ping Liang, Dharam Kaushik, Kenneth W Gross, Hyung L Kim.   

Abstract

Formalin-fixed paraffin-embedded (FFPE) tissues are routinely stored by most pathology departments and are a widely available resource for discovery of clinically useful biomarkers. We describe our method for optimizing quantitative reverse transcription PCR (RT-PCR) for expression analysis using frozen and archival tissue. Commonly used reference genes were evaluated for stability of expression in normal kidney and clear cell renal cell carcinoma (RCC). Optimal reference genes for calculating normalization factors for RT-PCR were ACTB, RPL13A, GUS, RPLP0, HPRT1, and SDHA when using FFPE RCC. The optimal reference genes when using frozen RCC were ACTB, RPL13A, and GUS, confirming that use of multiple reference genes improves accuracy when intact RNA from frozen renal tumors are used. Expression of 16 markers previously reported to have prognostic significance in RCC was determined in 23 matching frozen and FFPE renal tumors, representing a range of tumor grades and stages; correlation coefficient for expression measured in frozen and FFPE tumors was 0.921 (P < 0.001). All markers predicted survival when frozen tumors were used and 14 of the 16 markers predicted survival when FFPE tumors were used as the source of RNA. An optimized RT-PCR assay can accurately measure expression of most prognostic tumor markers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18072593     DOI: 10.2144/000112562

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  14 in total

1.  Quantitative expression profiling in formalin-fixed paraffin-embedded samples by affymetrix microarrays.

Authors:  Diana Abdueva; Michele Wing; Betty Schaub; Timothy Triche; Elai Davicioni
Journal:  J Mol Diagn       Date:  2010-06-03       Impact factor: 5.568

2.  Tubulocystic renal cell carcinoma: is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases.

Authors:  Petr Steiner; Milan Hora; Jan Stehlik; Petr Martinek; Tomas Vanecek; Fredrik Petersson; Michal Michal; Marie Korabecna; Ivan Travnicek; Ondrej Hes
Journal:  Virchows Arch       Date:  2013-01-08       Impact factor: 4.064

3.  Evaluation of a high-throughput, microfluidics platform for performing TaqMan™ qPCR using formalin-fixed paraffin-embedded tumors.

Authors:  Ping Li; Elena Grigorenko; Vince Funari; Edward Enright; Hao Zhang; Hyung L Kim
Journal:  Bioanalysis       Date:  2013-07       Impact factor: 2.681

4.  Deletions of 16q in Wilms tumors localize to blastemal-anaplastic cells and are associated with reduced expression of the IRXB renal tubulogenesis gene cluster.

Authors:  Linda Holmquist Mengelbier; Jenny Karlsson; David Lindgren; Ingrid Øra; Margareth Isaksson; Ildiko Frigyesi; Attila Frigyesi; Johannes Bras; Bengt Sandstedt; David Gisselsson
Journal:  Am J Pathol       Date:  2010-09-16       Impact factor: 4.307

5.  Maximizing RNA yield from archival renal tumors and optimizing gene expression analysis.

Authors:  Sean T Glenn; Karen L Head; Bin T Teh; Kenneth W Gross; Hyung L Kim
Journal:  J Biomol Screen       Date:  2009-12-11

6.  A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance).

Authors:  Hyung L Kim; Susan Halabi; Ping Li; Greg Mayhew; Jeff Simko; Andrew B Nixon; Eric J Small; Brian Rini; Michael J Morris; Mary-Ellen Taplin; Daniel George
Journal:  EBioMedicine       Date:  2015-09-08       Impact factor: 8.143

7.  Identification of novel reference genes using multiplatform expression data and their validation for quantitative gene expression analysis.

Authors:  Mi Jeong Kwon; Ensel Oh; Seungmook Lee; Mi Ra Roh; Si Eun Kim; Yangsoon Lee; Yoon-La Choi; Yong-Ho In; Taesung Park; Sang Seok Koh; Young Kee Shin
Journal:  PLoS One       Date:  2009-07-07       Impact factor: 3.240

8.  A comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma models.

Authors:  Hao Zhang; Dror Berel; Yanping Wang; Ping Li; Neil A Bhowmick; Robert A Figlin; Hyung L Kim
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

9.  Identification of a suitable qPCR reference gene in metastatic clear cell renal cell carcinoma.

Authors:  Piotr M Wierzbicki; Jakub Klacz; Agnieszka Rybarczyk; Tomasz Slebioda; Marcin Stanislawowski; Agata Wronska; Anna Kowalczyk; Marcin Matuszewski; Zbigniew Kmiec
Journal:  Tumour Biol       Date:  2014-09-16

10.  Whole-Transcriptome profiling of formalin-fixed, paraffin-embedded renal cell carcinoma by RNA-seq.

Authors:  Ping Li; Andrew Conley; Hao Zhang; Hyung L Kim
Journal:  BMC Genomics       Date:  2014-12-11       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.